|
CyVek, Inc. and SBH Sciences have initiated their collaboration with the first placement of the CyPlex System in the United States. Online PR News – 26-August-2014 – SBH Sciences, an innovative pre-clinical contract research organization, announced today that they have increased their service offerings through the addition of a newly introduced immunoassay-testing platform, CyPlex. The new platform was developed by CyVek, Inc, a Connecticut-based biotech firm that is transforming immunoassay testing by delivering an advanced, fully automated, multi-analyte bench top immunoassay system that integrates a microfluidic cartridge with a state-of-the-art analyzer. Dr. Raphael Nir, President and Chief Science Officer, SBH Sciences, said, We are excited and proud to be the first CRO to add this innovative analytical tool to our services list. We are routinely using Luminex and it would be interesting to compare the 10-plus year platform with the most advanced multi-analyte bench top immunoassay system. It is our strategy to offer the most advanced service to the biotech industry. Since we are among the world experts in cytokine research, and are welcoming new collaborative research studies, this new tool will substantially increase our capabilities.
Please help us out :
Will you offer us a hand? Every gift, regardless of size, fuels our future. Your critical contribution enables us to maintain our independence from shareholders or wealthy owners, allowing us to keep up reporting without bias. It means we can continue to make Jewish Business News available to everyone. You can support us for as little as $1 via PayPal at office@jewishbusinessnews.com. Thank you. Bill Dubiel, Chief Commercial Officer, CyVek, Inc., said, From our first meeting with SBH Sciences, Dr. Nir clearly saw how this new technology might help his business model. We are excited to work together with SBH Sciences CLIA-certified facility to move the CyPlex system to the next level of testing. CyPlexs ability to provide sample-to-answer test results with precision and accuracy in a sealed disposable device makes it broadly applicable across numerous sectors, including clinical applications and routine life sciences research. About SBH Sciences: SBH Sciences is an innovative pre-clinical contract research organization, located in Natick, Massachusetts. SBH Science’s unique assays and customized biological products enhance discovery and bio-pharmaceutical development in oncology and inflammation research. SBH Sciences has been chosen by over 120 biotechnology and pharmaceutical companies for their service needs since 1997. SBH Sciences is also the leader of a network of specialized technology partners and provides incubator-style support to startup companies. For more information about SBH Sciences please call 508-650-6218 Ext. 214 or visit us on the web at: www.sbhsciences.com About CyVek: CyVek is a privately funded biotechnology company dedicated to the advancement of healthcare by empowering researchers and clinicians with a disruptive technology, CyPlexTM, for performing multi-analyte immunoassays. For more information about CyVek, please call 203-679-0395 or visit us on the web at: www.cyplexsystems.com. |
| Justin Gardner |
| http://www.bldghealth.com |
| 858-437-2127 |
